Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-08FDA Approved: NITROGLYCERIN TRANSDERMAL INFUSION SYSTEM — Supplemental Application (Dr. Reddy's Laboratories, Inc.)
FDA approved a supplemental application for the Nitroglycerin Transdermal Infusion System from Dr. Reddy's Laboratories, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Teledi@Log - Tele-rehabilitation of Heart Patients [NA]
A completed clinical trial update for the Teledi@Log tele-rehabilitation program for heart patients, including conditions such as heart fail…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Salt Sensitivity, Cardiovascular and Metabolic Disease
A completed clinical trial investigating salt sensitivity in cardiovascular and metabolic diseases.
-
FDA approval · 2015-12-21FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc., granting approval for chang…
-
FDA approval · 2015-12-16FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for metoprolol succinate by Quallent Pharmaceuticals Health LLC, indicating approval of the suppleme…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-07Clinical Trial Update: To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of ivabradine for stable, symptomatic chronic angina. The current trial statu…
-
FDA approval · 2015-11-30FDA Approved: FELODIPINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Felodipine by Glenmark Pharmaceuticals Inc., updating the labeling. It confirms its use for hype…
-
FDA approval · 2015-11-24FDA Approved: NIFEDIPINE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for nifedipine by Upsher-Smith Laboratories, LLC, facilitating a labeling/strength update for the ge…
-
FDA approval · 2015-11-20FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.
-
FDA approval · 2015-10-28FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (ACI Healthcare USA, Inc.)
The FDA approved a supplemental application for amlodipine besylate from ACI Healthcare USA, Inc., effectively granting regulatory approval …
-
FDA approval · 2015-10-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (Actavis Pharma, Inc.), a generic product.
-
FDA approval · 2015-10-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Verapamil Hydrochloride (generic) from Chartwell RX, LLC.
-
FDA approval · 2015-10-02FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2015-10-02FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for amlodipine besylate as a generic product under an ANDA, expanding its availabilit…
-
FDA approval · 2015-10-02FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for a nifedipine product from Leading Pharma, LLC, associated with an approved generic (ANDA074045).
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Natural Ischaemic Preconditioning Before First Myocardial Infarction
The clinical trial evaluating natural ischemic preconditioning before a first myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: The PEARL 8.0 Post-Approval Study
The PEARL 8.0 post-approval trial for Class IV angina sponsored by Cardiogenesis (CryoLife) was terminated; results were posted in 2015.
-
FDA approval · 2015-09-25FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate by PD-Rx Pharmaceuticals, Inc. under ANDA 076719, allowing marketing of this…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Analysis of Myocardial Layer Specific Systolic and Diastolic Function During and After PCI [NA]
The completed trial from RWTH Aachen University analyzed layer-specific myocardial systolic and diastolic function during and after percutan…
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods [NA]
This clinical trial update from RWTH Aachen University discusses intraprocedural determination of myocardial vitality using two imaging meth…
-
FDA approval · 2015-09-18FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for amlodipine besylate (generic amlodipine) under an ANDA, allowing the update…
-
FDA approval · 2015-09-18FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application to add a 2.5 mg strength of amlodipine besylate for Oxford Pharmaceuticals’ generic product, expandi…
-
FDA approval · 2015-09-16FDA Approved: NADOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Nadolol tablets as a generic drug under an Original Application (ANDA 201893) from Aurobindo Pharma Limited. This approval make…
-
FDA approval · 2015-09-10FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC.
-
FDA approval · 2015-09-08FDA Approved: NIFEDIPINE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for nifedipine (ANDA075289), authorizing a modification to the approved gen…